IL116730A0 - Chemically modified interferon - Google Patents
Chemically modified interferonInfo
- Publication number
- IL116730A0 IL116730A0 IL11673096A IL11673096A IL116730A0 IL 116730 A0 IL116730 A0 IL 116730A0 IL 11673096 A IL11673096 A IL 11673096A IL 11673096 A IL11673096 A IL 11673096A IL 116730 A0 IL116730 A0 IL 116730A0
- Authority
- IL
- Israel
- Prior art keywords
- chemically modified
- modified interferon
- interferon
- chemically
- modified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37247895A | 1995-01-13 | 1995-01-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL116730A0 true IL116730A0 (en) | 1996-05-14 |
Family
ID=23468282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11673096A IL116730A0 (en) | 1995-01-13 | 1996-01-10 | Chemically modified interferon |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0804248A2 (en) |
| JP (1) | JPH10513440A (en) |
| KR (1) | KR19980701814A (en) |
| AU (1) | AU4751896A (en) |
| BR (1) | BR9607599A (en) |
| CA (1) | CA2209557A1 (en) |
| IL (1) | IL116730A0 (en) |
| WO (1) | WO1996021468A2 (en) |
| ZA (1) | ZA96206B (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2322229B1 (en) * | 2001-10-10 | 2016-12-21 | Novo Nordisk A/S | Remodeling and glycoconjugation of Factor IX |
| SG155777A1 (en) | 2003-04-09 | 2009-10-29 | Neose Technologies Inc | Glycopegylation methods and proteins/peptides produced by the methods |
| US8791070B2 (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX |
| US9005625B2 (en) | 2003-07-25 | 2015-04-14 | Novo Nordisk A/S | Antibody toxin conjugates |
| AU2004281780B2 (en) | 2003-10-14 | 2009-03-19 | F. Hoffmann-La Roche Ltd | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication |
| US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
| US20060040856A1 (en) | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
| ES2572779T3 (en) | 2004-10-29 | 2016-06-02 | Ratiopharm Gmbh | Remodeling and glucopegilation of Fibroblast Growth Factor (FGF) |
| WO2006074467A2 (en) | 2005-01-10 | 2006-07-13 | Neose Technologies, Inc. | Glycopegylated granulocyte colony stimulating factor |
| EP1871795A4 (en) | 2005-04-08 | 2010-03-31 | Biogenerix Ag | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| JP5216580B2 (en) | 2005-05-25 | 2013-06-19 | ノヴォ ノルディスク アー／エス | Glycopegylated factor IX |
| EP2305697A3 (en) | 2005-07-25 | 2011-07-27 | Intermune, Inc. | Macrocyclic inhibitors of Hepatitis C virus replication |
| US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
| US8119592B2 (en) | 2005-10-11 | 2012-02-21 | Intermune, Inc. | Compounds and methods for inhibiting hepatitis C viral replication |
| US20090048440A1 (en) | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
| AR078117A1 (en) | 2006-06-20 | 2011-10-19 | Protech Pharma S A | A RECOMBINANT MUTEIN OF THE GLICOSILATED HUMAN ALPHA INTERFERON, A CODIFYING GENE FOR SUCH MUTEIN, A METHOD OF PRODUCTION OF SUCH GENE, A METHOD FOR OBTAINING A EUCARIOTE CELL MANUFACTURING THIS MUTEINE, A METHOD FOR A MUTE DIFFERENT PROCEDURE |
| US20080280818A1 (en) | 2006-07-21 | 2008-11-13 | Neose Technologies, Inc. | Glycosylation of peptides via o-linked glycosylation sequences |
| US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
| ES2406267T3 (en) | 2007-04-03 | 2013-06-06 | Biogenerix Ag | Treatment methods using glycopegylated G-CSF |
| JP5876649B2 (en) | 2007-06-12 | 2016-03-02 | ラツィオファルム ゲーエムベーハーｒａｔｉｏｐｈａｒｍ ＧｍｂＨ | Improved process for producing nucleotide sugars |
| US20130189239A1 (en) | 2008-02-27 | 2013-07-25 | Novo Nordisk A/S | Conjugated Factor VIII Molecules |
| WO2011014882A1 (en) | 2009-07-31 | 2011-02-03 | Medtronic, Inc. | CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-α TO HEPATITIS C INFECTED PATIENTS |
| US20120123338A1 (en) | 2010-06-16 | 2012-05-17 | Medtronic, Inc. | Damping systems for stabilizing medications in drug delivery devices |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5372808A (en) * | 1990-10-17 | 1994-12-13 | Amgen Inc. | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
| KR950014915B1 (en) * | 1991-06-19 | 1995-12-18 | 주식회사녹십자 | Asialoglycoprotein-conjugated compounds |
| TW263437B (en) * | 1992-09-24 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
| CN1087093A (en) * | 1993-09-16 | 1994-05-25 | 华西医科大学药学院 | The galactosyl interferon conjugate of liver target |
-
1996
- 1996-01-10 IL IL11673096A patent/IL116730A0/en unknown
- 1996-01-11 WO PCT/US1996/000323 patent/WO1996021468A2/en not_active Application Discontinuation
- 1996-01-11 KR KR1019970705211A patent/KR19980701814A/en not_active Application Discontinuation
- 1996-01-11 JP JP8521789A patent/JPH10513440A/en active Pending
- 1996-01-11 CA CA002209557A patent/CA2209557A1/en not_active Abandoned
- 1996-01-11 BR BR9607599A patent/BR9607599A/en unknown
- 1996-01-11 EP EP96903420A patent/EP0804248A2/en not_active Withdrawn
- 1996-01-11 ZA ZA96206A patent/ZA96206B/en unknown
- 1996-01-11 AU AU47518/96A patent/AU4751896A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR19980701814A (en) | 1998-06-25 |
| EP0804248A2 (en) | 1997-11-05 |
| WO1996021468A2 (en) | 1996-07-18 |
| BR9607599A (en) | 1998-06-09 |
| AU4751896A (en) | 1996-07-31 |
| MX9705119A (en) | 1997-10-31 |
| JPH10513440A (en) | 1998-12-22 |
| CA2209557A1 (en) | 1996-07-18 |
| ZA96206B (en) | 1996-08-19 |
| WO1996021468A3 (en) | 1996-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1012232A1 (en) | Interferon solution | |
| ZA96206B (en) | Chemically modified interferon | |
| DE59607241D1 (en) | Endotracheal-tubus | |
| GB9503549D0 (en) | Binlatch | |
| DE59602888D1 (en) | Breitstreckaggregat | |
| DE59605001D1 (en) | Luftreinigungsgerät | |
| DE59602030D1 (en) | Zellige polyurethan-elastomere | |
| DE59602283D1 (en) | Inchbremseinrichtung | |
| EP0747060A3 (en) | Anti-plasma-antibody-preparation | |
| ZA964817B (en) | Centrifugal-separator | |
| AP9600802A0 (en) | Libricant | |
| DE59604506D1 (en) | Rückkühlsystem | |
| DE59604913D1 (en) | Carbonylverbindungen | |
| CA76097S (en) | Can | |
| AU1105P (en) | DALESE Metrosideros excelsus | |
| AU125852S (en) | Tea - towel | |
| AU124825S (en) | Quiltcover | |
| AU124982S (en) | Snow - bike | |
| AU125853S (en) | Tea - towel | |
| AU126739S (en) | Gamesboard | |
| AU126766S (en) | Gamesboard | |
| AU124824S (en) | Quiltcover | |
| AU129378S (en) | TeleChipper | |
| AU130380S (en) | Matting-tile | |
| AU131835S (en) | Gamesboard |